Skip to main content
Clinical Trials/NCT04880837
NCT04880837
Completed
N/A

Human Papillomavirus Education Programs

Ohio State University Comprehensive Cancer Center1 site in 1 country12 target enrollmentApril 27, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Human Papillomavirus-Related Carcinoma
Sponsor
Ohio State University Comprehensive Cancer Center
Enrollment
12
Locations
1
Primary Endpoint
Change in human papillomavirus (HPV) knowledge
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This clinical trial aims to implement a culturally-tailored educational outreach actives with the goal of increasing knowledge of human papillomavirus (HPV) types that can lead to cancer and uptake of the available vaccine. The initiative also addresses barriers to vaccination and refer people to sites where they can get the HPV vaccine (e.g., private doctor offices, community health clinics, school-based health centers, and health departments). The HPV education program may help increase HPV vaccination rates and ultimately prevent HPV-related cancers.

Detailed Description

PRIMARY OBJECTIVE: I. To implement culturally tailored educational outreach activities with the goal of increasing knowledge of HPV types that can lead to cancer and uptake of the available vaccine. OUTLINE: Participants attend educational session about HPV-related cancers, screening, and HPV vaccination and guidelines and receive informational infographic handout on HPV vaccination. Participants also complete surveys pre and post education session over 5 minutes each to assess HPV vaccination status among children of participants, HPV knowledge, and intentions to get the HPV vaccination, and screening among participants. Participants participate in surveys over telephone or face-to-face at 3 and 6 months.

Registry
clinicaltrials.gov
Start Date
April 27, 2022
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Electra Paskett

Principal Investigator

Ohio State University Comprehensive Cancer Center

Eligibility Criteria

Inclusion Criteria

  • 18 years of age and older
  • From Ohio

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in human papillomavirus (HPV) knowledge

Time Frame: Baseline up to 6 months

Change in knowledge and strength of intention to be vaccinated will be correlated with key outcomes, specifically actual vaccination and actions promoting vaccination (e.g., encouraging HPV vaccination with family/friends, talking to their doctor/provider about the HPV vaccine). Multivariable logistic regression analyses will be conducted to examine the impact of knowledge change and strength of intentions on these binary outcomes (vaccinated/not vaccinated and encouraged/did not encourage HPV vaccination) controlling for important covariates such as age, sex, race/ethnicity, education, primary language, and health insurance/health care coverage.

Study Sites (1)

Loading locations...

Similar Trials